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Since DeWood et al.’ described the occurrence of 
coronary thrombosis in acute myocardial infarction, 
there has been a renewed interest in thrombolytic 
therapy and the effects of subsequent reperfusion. 
Initial studies concerning reperfusion in animal 
models have demonstrated conflicting results.:!-lo 
Some investigators have described improvement in 
survival, infarct size, and left ventricular function 
following reperfusion, *Z-4 others have described little 
or no effect$T7 still others have described deteriora- 
tion and adverse effects.8-1o Clearly, there are a 
number of reasons for these discrepancies including 
the animal model used, the state of anesthesia, the 
length of coronary occlusion and reperfusion, and 
the methodology of assessment of functional re- 
sponse. However, there is little doubt that reperfu- 
sion is a complex phenomenon with the potential for 
heterogeneous effects. 
More recently, studies have focussed on the delay 
of functional recovery following coronary reflow- 
the “stunned” myocardium.11-15 Although it is clear 
that this phenomenon occurs commonly, there are 
several anima12s 3 and clinical16* l7 reperfusion studies 
which have demonstrated early functional recovery 
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following coronary reperfusion. We hypothesized 
that the coupling, or uncoupling, of myocardial 
perfusion and function may play an integral role in 
functional recovery. 
Previous animal studies of reperfusion have used 
radioactive microspheres to assess myocardial per- 
fusion and ultrasonic crystals to measure functional 
change. The recent development of the cardiac 
imaging techniques of single photon emission com- 
puted tomography and two-dimensional echocardi- 
ography has made it possible to make quantitative 
assessment of myocardial perfusion and function 
using methods that are applicable to man. In the 
present study, a canine model of coronary occlusion 
and reperfusion using single photon emission com- 
puted tomography and two-dimensional echocardi- 
ography to assess the effect of coronary reflow 
following prolonged occlusion on myocardial reper- 
fusion and functional recovery was investigated. 
METHODOLOGY 
Eleven conditioned dogs were studied. Each dog 
was anesthetized with morphine, 3 mg per kg intra- 
muscularly, and sodium pentobarbitol, 30 mg per kg 
intravenously. Artificial respiration was maintained 
with a Harvard respirator. Using sterile surgical 
techniques, a left thoracotomy was performed, and 
the circumflex branch of the left coronary artery was 
dissected free from surrounding tissue. A mercury- 
filled cuff occluder was implanted on the left cir- 
cumflex coronary artery and was controlled exter- 
nally by a piston screw device. Coronary occlusion 
was estimated from the number of turns of the screw 
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following precallibration prior to implantation. Cor- 
onary occlusion was subsequently confirmed in-vivo 
after implanting the occluder by turning the screw 
the same number of times under direct visualization. 
Coronary occlusion was associated with typical ECG 
changes on test occlusion. In three of the dogs, an 
electromagnetic flow probe was implanted on the 
left circumflex coronary artery proximal to the cuff 
occluder. Indwelling catheters were placed in the 
ascending aorta and left atrium for pressure mea- 
surements and subsequent microsphere injection. 
An indwelling catheter was also implanted in the 
superior vena for pressure measurement and injec- 
tion of drugs. The catheters were brought out of the 
chest through a subcutaneous tunnel to the back 
and were secured to the skin between the scapulae. 
The chest cavity was closed and the pneumothorax 
was evacuated. Catheters were flushed daily with 
1000 U/ml of heparin. Antibiotics were administered 
intramuscularly prior to and following the surgery. 
The animals were kept in individual air-conditioned 
cages and were allowed to recover from surgery for 
14 days. 
Radionuclide imaging technique. For each imaging 
study, the animals were positioned within a rotating 
gamma camera tomograph. The detector was 
equipped with a high-resolution, low-energy, paral- 
lel hole collimator. The detector was positioned as 
close to the animal as possible while still permitting 
unobstructed rotation. For the thallium study, two 
mCi of thallium-201 were injected intravenously and 
imaging was begun 10 minutes later. Images were 
acquired over a 180-degree arc extending from the 
right lateral position to the left lateral position. 
Individual 30-second images were acquired every 5.8 
degrees of rotation to provide 32 total images. Each 
image was digitized into a 64 X 64 matrix and was 
stored on a magnetic disk in a small computer. 
Tomographic sections encompassing the entire vol- 
ume of the myocardium were then reconstructed 
using a filtered back projection algorithm without 
attenuation compensation.‘s 
Immediately after the thallium-201 tomograms 
were completed, the camera was repeaked for tech- 
netium-99m and the study was repeated using tech- 
netium-99m labeled microspheres. Two mCi of 
tagged microspheres were injected into the left 
atrium and imaging was begun 2 to 3 minutes later. 
The same imaging parameters were used for the 
microsphere study as were used for the thallium 
study. 
Radionuclide image quantification. The recon- 
structed tomographic sections were displayed on a 
computer terminal. Using the computer display, the 
operator identified an appropriate starting point 
within the perfused volume of myocardium. An 
automatic program then traced out the total volume 
corresponding to perfused myocardium on all con- 
tinguous tomographic sections (Fig. 1). The algo- 
rithm used was based on a region growing technique 
that determined the border of the perfused zone 
based on threshold and rate-of-change criteria. The 
method was previously validated on phantom stud- 
ies and was found to be accurate over the range of 20 
to 400 cc. The total volume of the perfused region 
was then calculated by multiplying the volume of a 
single pixel (0.25 cc) by the total number of pixels 
within the computer-defined perfused volume. 
Two-dimensional echocardiographic studies. Two- 
dimensional echocardiograms were performed as 
previously described,” with the animal in the right 
lateral decubitus position on a specially constructed 
table with a cutout allowing transducer positioning 
below the right lateral precordium. The best acous- 
tic window was determined and marked externally 
with ink to insure reproducible external positioning 
of the transducer. Hard copies of end-diastolic and 
end-systolic freeze frames were generated in the 
short-axis projection at the midpapillary muscle 
level for quantitative analysis. Using these freeze 
frames, the endocardial border was manually digi- 
tized and the area ejection fraction was calculated 
as: end-diastolic area - end-systolic area/end-dia- 
stolic area x 100%. Regional area ejection fraction 
was calculated using computer-aided processing as 
previously described. 2o In brief, an automatic pro- 
gram calculates the center of mass of the diastolic 
endocardial border, the rotation angle, and transla- 
tion coordinates for alignment of the systolic bor- 
ders over the diastolic borders. Using a fixed end- 
diastolic center of mass, our program divides each 
frame into 16 to 24 radial segments for calculations 
of the regional area ejection fraction. Specific 
regions of interest for regional analysis were selected 
by superimposing the functional map over the corre- 
sponding pathologic slab using the papillary muscles 
as landmarks. 
We have previously validated the accuracy of 
quantitative two-dimensional echocardiography 
(2DE) measures in our laboratory.*l In the present 
study, interobserver variability for the area ejection 
fraction was determined by dividing the difference 
between observers by the means of their observa- 
tions. Variability of the area ejection fraction mea- 
surements ranged from 4.4 % to 10.4 % . This degree 
of variability is acceptable and is comparable to that 
reported by Moynihan et al.= 
Specific protocol. At 14 days following surgery, 
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each conscious dog was studied. After baseline echo- 
cardiographic imaging, constriction of the circum- 
flex coronary artery was achieved in the conscious, 
sedated animal by a few turns of the screw-driven 
piston on the occluder. Coronary occlusion was 
estimated from the number of turns of the screw 
following precallibration prior to implantation. Cor- 
onary occlusion was associated with typical ECG 
changes, regional wall motion, and wall thickening 
abnormalities on 2DE. Beginning 3 hours after 
occlusion, each animal underwent echocardiograph- 
ic, thallium-201, and technetium-99m microsphere 
imaging studies. Circumflex coronary artery flow 
was then reestablished after 4.7 -t 0.3 hours by 
completely releasing the occluder under echocardio- 
graphic monitoring. At 7 days after occlusion, the 
seven surviving animals again underwent echocar- 
diographic, thallium-201, and technetium-99m 
microsphere radionuclide imaging studies. 
Pathologic quantitation. Following the second set of 
images, the dogs were killed and the excised hearts 
were rinsed with saline and were then attached to a 
perfusion apparatus. 23 The coronary circulation was 
flushed by perfusing the aorta with 1 L of warm 
saline. Next, the left circumflex coronary artery was 
cannulated at the point of previous occlusion and 
was perfused with warm, buffered triphenyltetrazol- 
ium chloride (TTC), while buffered 0.13% Evans 
blue dye was delivered at equal pressure (100 mm 
Hg) into the aorta. Differential perfusion of the :left 
circumflex coronary artery and remaining vacula- 
ture under these conditions delineated the anatomic 
area at risk, as well as the infarcted myocardium, 
based on the ability of dehydrogenases present in 
viable, perfused myocardium to react with TTC. 
With this staining technique, the myocardium that 
was not part of the area at risk was stained dark 
blue. Within the boundaries of the area at risk, 
normal tissue was stained brick red by the TTC, 
while infarcted myocardium appeared pale yellow. 
After approximately 15 minutes, the perfusion- 
stained hearts were sliced transversely into five or 
six 1 cm thick sections. The outlines of the infarcted 
and risk areas were traced on transparent overlays, 
and the fraction of the risk area in the left ventricle 
occupied by infarcted tissue was determined by 
manually digitizing these tracings and computer 
processing. The perfused myocardium (area not at 
risk), risk area, and infarcted tissue were then 
expressed as a percentage of the total left ventricu- 
lar mass. The perfused myocardial (non-risk) mass 
during coronary occlusion was calculated as: total 
left ventricular mass - (risk + infarct) mass. The 
perfused myocardial (non-risk) mass at 7 days was 
Fig. 1. Reconstructed short-axis view of Tl-201 tomo- 
graph (left paneZ) with sizing program outlining volume 
corresponding to perfused myocardium (right panel). See 
text for details. Z-201 = thallium-201. 
















79 -* 76 
140 151 128 
59 65 92 
85 85 80 
86 -* 18 
83 80 76 
93 116 100 
142 136 137 
98 117 103 
94 107 103 
Tc-99m = technetium-99m. 
*Technically inadequate study 
considered: total left ventricular mass - infarct 
mass. 
Statistical analysis. Multiple comparisons were 
performed using a two-way analysis of variance with 
Tukey’s test for multiple differences. In addition, 
paired, or unpaired, t tests were performed for 
analysis of changes in reperfused groups. Correla- 
tions were calculated using least squares linear 
regression. All data are expressed as mean -+ stan- 
dard deviation of the mean. 
OBSERVATIONS 
A total of 11 dogs weighing 31 + 3 kg underwent 
surgery and chronic instrumentation. Following left 
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Fig. 2. Correlation between Tc-99m-derived perfused 
myocardial mass (during occlusion) and actual perfused 
mass measured pathologically. Tc-99n = technetium-99m 
microsphere. 

































Tc-99m = technetium-99m. 
*Dog died. 
tTechnicaUy inadequate study. 
circumflex coronary occlusion, one dog fibrillated 
and died approximately 20 minutes following occlu- 
sion. The remaining 10 dogs underwent circumflex 
occltiion. for an average of 4.7 -+ 0.3 hours followed 
by abrupt and complete release of the occlusion. In 
the three dogs with electromagnetic flow probes, 
coronary release was associated with immediate 
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Fig. 3. Correlation between Tl-201 SPECT-derived per- 
fused myocardial mass (during occlusion) and actual 
perfused mass measured pathologically. Tl-201 = thalli- 
um-201. 
which were maintained on repeat study at 7 days. 
Of the 10 dogs surviving coronary occlusion and 
reflow, one dog died suddenly 24 hours post occlu- 
sion, one dog died on day 3, and one dog died on day 
4. The remaining seven animals survived the full 
‘I-day study period. 
SPECT data. The individual data from the single 
photon emission computed tomography studies with 
thallium-201 and technetium-99m microspheres, 
and the pathologic data are summarized in Tables I 
and II. The pathologically measured risk area was 
37 + 6%) and infarct size was 11 + 9% of the total 
left ventricle. Infarct/risk ratio was 32 +- 31%. 
The average perfused myocardial mass during 
coronary occlusion determined by technetium-9Bm 
microsphere single photon emission computed 
tomography (SPECT) was 107 f 25 gm, and by 
thallium-201 SPECT it was 96 + 25 gm. These 
values correlated well with the actual nonischemic 
myocardial (non-risk) mass of 97 + 22 gm as mea- 
sured at pathology (r = 0.87) (Figs. 2 and 3). In 
addition, the perfused myocardial mass by SPECT 
using the two radiopharmaceuticals correlated well 
with each other (r = 0.93) (Fig. 4). At 7 days, 
thallium-201 SPECT measured 128 & 36 gm and 
correlated well with pathology (145 f 34 gm, 
T = 0.90) and technetium-99 microsphere SPECT 
(130 & 47, r = 0.98). 
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2DE data. The individual area ejection fraction 
data from the two-dimensional echocardiography 
(2DE) studies are presented in Table III. With 
coronary occlusion, area ejection fraction decreased 
from 57 * 13% to 36 f 16% 0, < 0.01). Following 
coronary release, there was an improvement in area 
ejection fraction (36 f 16 % to 44 * 16 % , p < 0.05) 
which remained constant (47 f 12 % , p = NS) at 1 
week. There was no change in regional ejection 
fraction in the nonischemic segment from baseline 
(58 ? 19%) to occlusion (48 5 19%) to immediate 
reperfusion (52 f 22%) to 1 week (47 + 27%) all 
p = NS). Regional ejection fraction in the central 
ischemic zone fell significantly with coronary occlu- 
sion (69 & 22% to 26 + 35%) p < 0.05), remained 
depressed with immediate reperfusion (35 + 28%) 
p < 0.05), but recovered by 1 week (48 f 19%) 
p = NS vs control). 
SPECT-2DE relationship. Two subgroups of dogs 
who survived the protocol were identified during the 
reperfusion imaging studies at day 7. Three of seven 
animals showed evidence of adequate reperfusion 
(>20%) by both thallium-201 and technetium-99m 
microsphere SPECT (Fig. 5). In these animals, there 
was a mean increase in the measured perfused mass 
of 47.7%. Four animals showed evidence of inade- 
quate reperfusion (<20% ) by both thallium-201 and 
technetium-99m microsphere SPECT (Fig. 6). In 
this group, the mean increase in the perfused mass 
was only 6.5%. Comparing those animals with ade- 
quate reperfusion to those with inadequate reperfu- 
sion, there was no difference in occlusion times 
(4.7 +_ 0.7 hours vs 4.5 f 0.6%, p = NS) or infarct 
size (7.8 -t 3.5% vs 10.0 rf: 5%, p = NS). However, 
the change in area ejection fraction determined by 
2DE was significantly greater in those animals who 
had SPECT evidence of adequate reperfusion (34 + 
19% vs 4 f 16%, p < 0.05). After 7 days, the change 
in area ejection fraction determined by 2DE was 
similar in both subgroups (44 -+ 31% vs 32 + 
92%, p = NS). 
COMMENTS 
Our data indicate that the mass of perfused 
myocardium estimated by thallium-201 or techne- 
tium-99m microsphere SPECT corresponds well to 
the actual viable perfused myocardial mass during 
acute coronary occlusion. However, after a lengthy 
coronary occlusion of almost 5 hours, significant 
reperfusion by thallium-201 uptake occurred in only 
three of seven dogs. Conversely, in the remaining 
four surviving animals, there was evidence of 
decreased perfusion to the histologically defined 
at-risk zone, suggesting either infarction or severe 
r.O.93 
yso.97x + 10.0 
195 
-z 180. 








Fig. 4. Correlation between Tl-201 derived myocardial 
mass (during occlusion) and Tc-99m myocardial mass 
(during occlusion). Tc-99m = technetium-99m micro- 
sphere; Tl-201 = thallium-201. 
Table III. Area ejection fraction by 2DE 
Dog Baseline 







1 60 41 63 60 
2 52 48 39 56 
3 42 23 39 -* 
4 65 22 i8 48 
5 71 46 70 -* 
6 80 54 53 -t 
7 53 14 41 -* 
8 35 19 31 34 
9 65 59 62 30 
10 50 38 42 48 
2DE = two-dimensional echocardibgraphy; EF = ejection fraction. 
*Dog died. 
t2DE study not done. 
persistent ischemia. Since the histologic staining 
demonstrating triphenyltetrazolium chloride stain- 
ing of much of this zone implied tissue viability, the 
lack of thallium-201 and technetium-99m micro- 
sphere uptake mqst likely indicated severe persis- 
tent hypoperfusion. Furthermore, the 2DE studies 
suggested that the degree of reperfusion predicted 
the early change in ieft ventricular function; those 
animals with good reperfusion had significantly 
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Occlusion Reperfusion 
Fig. 5A. Reconstructed short-axis thallium tomograph demonstrating a large posterior perfusion defect 
during left circumflex coronary occlusion (left panel) and marked improvement in perfusion in the 
posterior region (right panel). Quantitatively, the improvement in perfusion was 49%. 
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Fig. 58. Corresponding functional data in the same animal as in Fig. 5A. The regional area ejection 
fraction is measured at 22.5degree intervals and mapped circumferentially over 360-degrees. Note the 
marked wall motion abnormality in the region of the PPM corresponding to the thallium-201 perfusion 
defect during coronary occlusion. With coronary release, there is good functional recovery, corresponding 
to the reperfusion noted on thallium-201 tomography. PPM = posterior papillary muscle. 
better early functional recovery than those with 
poor reperfusion. However, by day 7 further 
improvement in functional recovery was apparent in 
both groups despite the degree of reperfusion. 
The “no-reflow” phenomenon. Two well described 
reperfusion phenomena may help explain these 
findings: (1) the “no-reflow” phenomenon,24-26 and 
(2) the delayed functional recovery of myocardial 
tissue-the “stunned” myocardium.11-15 The no- 
reflow phenomenon is thought to be related to 
microvascular injury occurring with coronary occlu- 
sions greater than 90 minutes. Swollen perivascular 
and endothelial cells develop during ischemia and 
contribute to the obstruction of capillaries in the 
ischemic zone. Although the no-reflow phenomenon 
is usually most apparent in the central ischemic 
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Occlusion Reperfusion 
Fig. 6A. Reconstructed short-axis thallium tomograph demonstrating a large perfusion defect during left 
circumflex coronary occlusion (left panel). Following coronary reflow (right panel), there is little 
improvement in myocardial perfusion, which was quantitatively 5%. 
------.-.. ----Reperfuslon 
PPM 
0 45 90 135 I 180 225 270 315 360 
Circumferential Angle (‘1 
Fig. 6B. Corresponding functional data in the same animal as in Fig. 6A. The regional area ejection 
fraction is measured at 22.5-degree intervals and mapped circumferentially over 360 degrees. Note the 
marked wall motion abnormality in the region of the PPM corresponding to the thallium-201 perfusion 
defect during coronary occlusion. With coronary release, there is no functional recovery corresponding to 
poor reperfusion noted on the thallium-201 tomograph. PPM = posterior papillary muscle. 
zone, hypoperfusion in ischemic but viable myocar- factor contributing to no-reflow may be the method 
dial tissue has been described.13 Recent clinical and degree of reestablishment of coronary flow. In 
studies suggest that myocardial perfusion is reestab- the present experiments, there was abrupt release of 
lished following thrombolytic therapy;27-2g however, the coronary occlusion which may have contributed 
the degree and significance of the no-reflow phe- to microvascular damage. A slow, limited reestab- 
nomenon in man is incompletely understood. A lishment of coronary flow, as may occur with strep- 
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tokinase thrombolytic therapy, may have different 
effects on tissue perfusion and viability. 
“Stunned” myocardium. The “stunned” myocardi- 
urn haa been described by several investigatorsll-l5 as 
a delay in functional recovery of the myocardium 
following coronary reflow. Although the pathophysi- 
ology of this phenomenon is not completely under- 
stood, delay in recovery of high energy phosphates 
and abnormalities in calcium flux following reperfu- 
sion may be contributing factors. Our data suggest 
that some early myocardial functional recovery may 
occur and may be predicted by the degree of reper- 
fusion. Those animals with persistent hypoperfusion 
following coronary reflow had poor early functional 
recovery, with gradual improvement of “stunned” 
myocardial tissue over the subsequent 7 days. 
It is possible that the generally small size of the 
infarcts in the animals influenced our functional 
results, since only 32% of the risk region was 
infarcted. There are a number of possible explana- 
tions for the limited infarct size in our animals. 
First, all animals were pretreated with a beta block- 
er to reduce the incidence of occlusion arthythmas, 
and this may have limited infarct size.3o Secondly, it 
is possible that collateral development was stimu- 
lated by the chronically applied occluder, which 
subsequently limited the degree of necrosis. Thirdly, 
it is possible that the risk region was overestimated 
by our in-vitro technique of dual perfusion staining, 
particularly in the setting of chronic collateral devel- 
opment. Whatever the mechanism, it is clear that 
our animals had limited infarctions despite &hour 
coronary occlusions, and this may have influenced 
the changes in left ventricular function which we 
observed. 
There have been conflicting clinica116~31~32 and 
animal data2-lo concerning the early recovery of 
global left ventricular function following thromboly- 
sis. It is possible that these discrepancies may be 
related to the no-reflow phenomenon, producing 
severe hypoperfusion and subsequently a “stunned” 
myocardium. Of equal importance is the consider- 
ation of the type of analysis of left ventricular 
function performed. In this study, 2DE was used to 
provide tomographic information concerning region- 
al function of a slice of myocardium. There have 
been previous reports that changes in global left 
ventricular function using traditional indices of left 
ventricular volumes and ejection fraction may mini- 
mize or mask changes that are only detected by 
regional assessment.33 
Another possible explanation for our reperfusion 
findings is that the long period of tissue ischemia 
altered the uptake pattern of thallium in otherwise 
viable myocardial cells. This alternative hypothesis 
seems unlikely on theoretical grounds and is also 
refuted by the corollary experiments with techne- 
tium-99m microspheres. All of the animals demon- 
strating lack of reperfusion on the late studies by 
thallium-201 also demonstrated this phenomenon in 
the microsphere studies. Since the only common 
mechanism of distribution between these two trac- 
ers is tissue blood flow, this provides strong support- 
ing evidence that persistent ischemia in a zone of 
still viable myocardium is indeed the reason for 
these findings. 
SPECT imaging. In previous experiments, several 
investigators34,35 have demonstrated the usefulness 
of SPECT in localizing acute myocardial infarction 
as small as 2 gm in size using technetium-99m 
pyrophosphate in dogs. Subsequent studie@ in the 
canine heart in vitro demonstrated the ability of 
SPECT with thallium-201 to accurately measure 
total and infarcted myocardial mass. Since thallium- 
201 is only distributed to viable myocardium, the 
definition of the infarcted myocardium required 
certain assumptions regarding endocardial and epi- 
cardial borders in regions lacking thallium-201 
uptake. While these studies appear to give valid 
results in the nonbeating canine heart in vitro, it is 
recognized that assumptions of wall thickness and 
shape may not be valid in the beating in-vivo canine 
heart. In addition, the technique used to define the 
nonvisualized myocardial segment was not applica- 
ble to infarctions which encompass the area of the 
left ventricular apex. For these reasons, no attempts 
were made in the present study to directly measure 
infarct size. Rather, total perfused myocardial mass, 
as reflected by thallium-201 uptake or technetium- 
99m microsphere distribution, was quantified and 
changes in this mass over time were used to infer 
changes in the mass of myocardium at risk and total 
infarct mass. Thus, our data confirm the ability of 
SPECT to estimate myocardial mass in vivo and 
agree with the recent experience of others?“” 
In summary, this study demonstrates that 
SPECT with both thallium-201 and technetium- 
99m microspheres has sufficient accuracy to quanti- 
tate perfused myocardial mass during acute isch- 
emia and following completed infarction. Coronary 
reflow does not necessarily predict adequate myo- 
cardial reperfusion, since the “no-reflow” phenome- 
non may be a significant factor following prolonged 
occlusion. Regional assessment of left ventricular 
function using 2DE demonstrates early but incom- 
plete functional recovery in those animals who were 
adequately reperfused, but poor functional recovery 
in those with inadequate reperfusion. These obser- 
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vations may have important clinical implications in 
patients who receive thrombolytic therapy. Further- 
more, this study demonstrates the potential of using 
SPECT and 2DE in the clinical assessment of 
thrombolytic therapy. 
CONCLUSIONS 
To further understand the interrelationship of 
myocardial perfusion and function following coro- 
nary occlusion and reflow, 10 chronically instru- 
mented closed-chest dogs were studied. Serial 2DE 
was performed at baseline, following occlusion, dur- 
ing early reperfusion, and at 7 days. Serial thallium- 
201 (TL-201) SPECT was done during coronary 
occlusion and at 7 days. Following coronary occlu- 
sion, there was a large perfusion defect on Tl-201 
SPECT accompanied by a decrease in 2DE left 
ventricular area ejection fraction from 57 + 13% to 
36 & 16% (p < 0.01). After 5 hours of coronary 
occlusion, coronary reflow produced an improve- 
ment in myocardial perfusion on Tl-201 SPECT 
(96 + 25 to 128 f 36 gm, p < 0.05), accompanied by 
an improvement in 2DE area ejection fraction (44 :+ 
16%) p < 0.05). However, animals with better reper- 
fusion had significantly better functional recovery 
than those with a “no-reflow” phenomenon 
(p < 0.05). After 1 week, there was further function- 
al improvement in both groups. Our data suggest 
that coronary reflow produces varying degrees of 
myocardial reperfusion which may affect early func- 
tional recovery. 
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